BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats

G. Bárdos, K. Móricz, L. Jaszlits, G. Rabloczky, K. Tory, I. Rácz, S. Bernáth, B. Sümegi, B. Farkas, B. Literáti-Nagy, P. Literáti-Nagy

Research output: Contribution to journalArticle

40 Citations (Scopus)


The neuroprotective effect of BGP-15 against peripheral sensory neuropathy was studied in rats that were exposed to short-term cisplatin or taxol administration. The changes of nerve conduction velocity were determined in situ after treating the Wistar rats with BGP-15 (50, 100, and 200 mg/kg po daily doses throughout the experiment), cisplatin (1.5 mg/kg ip daily dose for 5 days), or taxol (5.0 mg/kg ip daily dose every other day in a 10-day interval) alone or giving the test compound in combination with cisplatin or taxol. Electrophysiological recordings were carried out in vivo by stimulating the sciatic nerve at both sciatic notch and ankle site. Neither motor nor sensory nerve conduction velocity was altered by any dose level of BGP-15 tested. Both anticancer drugs decreased the sensory nerve conduction velocity (SNCV). BGP-15 treatment prevented the impairment of SNCV either in part or totally in the cisplatin- or taxol-treated groups. This neuroprotective potential of BGP-15 could be well correlated with its recently described poly(ADP-ribose) polymerase-inhibitory effect and its ability to protect against the damages induced by the increased level of reactive oxygen species in response to anticancer treatment.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalToxicology and Applied Pharmacology
Issue number1
Publication statusPublished - Jul 1 2003


  • BGP-15
  • Cisplatin
  • Modulation of PARP activity
  • Nerve conduction velocity
  • Peripheral sensory neuropathy
  • Poly(ADP-ribose) polymerase (PARP) enzyme
  • Prevention of neuropathy
  • Taxol
  • Toxic effects of antitumor drugs

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats'. Together they form a unique fingerprint.

  • Cite this